Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
October-2017 Volume 38 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2017 Volume 38 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy

  • Authors:
    • Jintian Tang
    • Jianghua Ou
    • Chunyan Xu
    • Chao Yi
    • Feng Xue
    • Lin Xu
    • Fenju Lai
    • Jianjun Tang
    • Shengping Li
    • Tiebang Kang
    • Wei Ding
    • Boqing Wang
  • View Affiliations / Copyright

    Affiliations: Department of Hepatopancreatobiliary Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P.R. China, Department of Breast Surgery, Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang, P.R. China, College of Bioscience and Engineering, Jiangxi Engineering Laboratory for the Development and Utilization of Agricultural Microbial Resources, Jiangxi Agricultural University, Nanchang, Jiangxi, P.R. China, Department of Gastroenterology, Cancer Hospital of Jiangxi Province, Nanchang, Jiangxi, P.R. China, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, P.R. China
  • Pages: 2251-2258
    |
    Published online on: August 1, 2017
       https://doi.org/10.3892/or.2017.5862
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The present study explored the correlation of ecotropic viral integration site 5 (EVI5) expression with clinicopathological features and prognosis in hepatocellular carcinoma (HCC). A total of 205 HCC patients were included retrospectively. Quantitative real-time polymerase chain reaction (RT-qPCR) and western blotting were performed to detect the profile of EVI5 expression in HCC cell lines and fresh tissues. Archived paraffin-embedded specimens were investigated for EVI5 expression by immunohistochemistry (IHC). Both the mRNA and protein levels of EVI5 were obviously upregulated in HCC cell lines and tumor tissues. EVI5 protein level was closely associated with the clinicopathological characteristics, including liver function (P=0.013), venous invasion (P=0.015) and TNM stage (P=0.014). Furthermore, univariate analysis showed that the patients with high EVI5 expression indicated shorter overall survival (OS, P<0.001) and recurrence-free survival (RFS, P=0.001) than those with low EVI5 expression. Importantly, high EVI5 expression also exerts predictive power for higher postoperative recurrence rate by stratified analysis. Multivariate Cox regression analysis demonstrated that OS was correlated with both tumor number (P=0.046) and EVI5 expression (P<0.001) and that RFS was correlated with serum AFP (P=0.023), tumor number (P=0.036) and EVI5 expression (P<0.001). Taken together, EVI5 is an useful independent prognostic marker of survival and recurrence in hepatocellular carcinoma.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China, 2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI

4 

Chen S, Ling Q, Yu K, Huang C, Li N, Zheng J, Bao S, Cheng Q, Zhu M and Chen M: Dual oxidase 1: A predictive tool for the prognosis of hepatocellular carcinoma patients. Oncol Rep. 35:3198–3208. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Wu Y, Lin X, Di X, Chen Y, Zhao H and Wang X: Oncogenic function of Plac1 on the proliferation and metastasis in hepatocellular carcinoma cells. Oncol Rep. 37:465–473. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Roberts T, Chernova O and Cowell JK: NB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastoma. Hum Mol Genet. 7:1169–1178. 1998. View Article : Google Scholar : PubMed/NCBI

7 

Didonna A, Isobe N, Caillier SJ, Li KH, Burlingame AL, Hauser SL, Baranzini SE, Patsopoulos NA and Oksenberg JR: A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome. Hum Mol Genet. 24:7151–7158. 2015.PubMed/NCBI

8 

Liu J, Liu X, Liu Y, Deng S, Huang H, Chen Q, Liu W and Huang Z: Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis. Meta Gene. 9:97–103. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Westlake CJ, Junutula JR, Simon GC, Pilli M, Prekeris R, Scheller RH, Jackson PK and Eldridge AG: Identification of Rab11 as a small GTPase binding protein for the Evi5 oncogene. Proc Natl Acad Sci USA. 104:1236–1241. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Eldridge AG, Loktev AV, Hansen DV, Verschuren EW, Reimann JD and Jackson PK: The evi5 oncogene regulates cyclin accumulation by stabilizing the anaphase-promoting complex inhibitor emi1. Cell. 124:367–380. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Faitar SL, Sossey-Alaoui K, Ranalli TA and Cowell JK: EVI5 protein associates with the INCENP-aurora B kinase-survivin chromosomal passenger complex and is involved in the completion of cytokinesis. Exp Cell Res. 312:2325–2335. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Liao X, Buchberg AM, Jenkins NA and Copeland NG: Evi-5, a common site of retroviral integration in AKXD T-cell lymphomas, maps near Gfi-1 on mouse chromosome 5. J Virol. 69:7132–7137. 1995.PubMed/NCBI

13 

Baron BW, Anastasi J, Bies J, Reddy PL, Joseph L, Thirman MJ, Wroblewski K, Wolff L and Baron JM: GFI1B, EVI5, MYB - additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas. Blood Cells Mol Dis. 52:68–75. 2014. View Article : Google Scholar : PubMed/NCBI

14 

Heber-Katz E, Zhang Y, Bedelbaeva K, Song F, Chen X and Stocum DL: Cell cycle regulation and regeneration. Curr Top Microbiol Immunol. 367:253–276. 2013.PubMed/NCBI

15 

Wang B, Tang J, Liao D, Wang G, Zhang M, Sang Y, Cao J, Wu Y, Zhang R, Li S, et al: Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Ann Surg Oncol. 20 Suppl 3:S684–S692. 2013. View Article : Google Scholar : PubMed/NCBI

16 

Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B and Mouridsen HT: Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: A comparison between whole sections and tissue microarrays. J Clin Pathol. 60:397–404. 2007. View Article : Google Scholar : PubMed/NCBI

17 

Liao WT, Guo L, Zhong Y, Wu YH, Li J and Song LB: Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. J Transl Med. 9:2052011. View Article : Google Scholar : PubMed/NCBI

18 

Faitar SL, Dabbeekeh JT, Ranalli TA and Cowell JK: EVI5 is a novel centrosomal protein that binds to alpha- and gamma-tubulin. Genomics. 86:594–605. 2005. View Article : Google Scholar : PubMed/NCBI

19 

Fuchs E, Haas AK, Spooner RA, Yoshimura S, Lord JM and Barr FA: Specific Rab GTPase-activating proteins define the Shiga toxin and epidermal growth factor uptake pathways. J Cell Biol. 177:1133–1143. 2007. View Article : Google Scholar : PubMed/NCBI

20 

Li Y, Xu D, Bao C, Zhang Y, Chen D, Zhao F, Ding J, Liang L, Wang Q, Liu L, et al: MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma. Oncotarget. 6:2421–2433. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Scaravilli M, Asero P, Tammela TL, Visakorpi T and Saramäki OR: Mapping of the chromosomal amplification 1p21-22 in bladder cancer. BMC Res Notes. 7:5472014. View Article : Google Scholar : PubMed/NCBI

22 

Varghese S, Xu H, Bartlett D, Hughes M, Pingpank JF, Beresnev T and Alexander HR Jr: Isolated hepatic perfusion with high-dose melphalan results in immediate alterations in tumor gene expression in patients with metastatic ocular melanoma. Ann Surg Oncol. 17:1870–1877. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Jacob B, Osato M, Yamashita N, Wang CQ, Taniuchi I, Littman DR, Asou N and Ito Y: Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood. 115:1610–1620. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Verschuren EW, Ban KH, Masek MA, Lehman NL and Jackson PK: Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence. Mol Cell Biol. 27:7955–7965. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Rao N, Jhamb D, Milner DJ, Li B, Song F, Wang M, Voss SR, Palakal M, King MW, Saranjami B, et al: Proteomic analysis of blastema formation in regenerating axolotl limbs. BMC Biol. 7:832009. View Article : Google Scholar : PubMed/NCBI

26 

Emery G, Hutterer A, Berdnik D, Mayer B, Wirtz-Peitz F, Gaitan MG and Knoblich JA: Asymmetric Rab 11 endosomes regulate delta recycling and specify cell fate in the Drosophila nervous system. Cell. 122:763–773. 2005. View Article : Google Scholar : PubMed/NCBI

27 

Longatti A, Lamb CA, Razi M, Yoshimura S, Barr FA and Tooze SA: TBC1D14 regulates autophagosome formation via Rab11- and ULK1-positive recycling endosomes. J Cell Biol. 197:659–675. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Giansanti MG, Belloni G and Gatti M: Rab11 is required for membrane trafficking and actomyosin ring constriction in meiotic cytokinesis of Drosophila males. Mol Biol Cell. 18:5034–5047. 2007. View Article : Google Scholar : PubMed/NCBI

29 

Kawauchi T, Sekine K, Shikanai M, Chihama K, Tomita K, Kubo K, Nakajima K, Nabeshima Y and Hoshino M: Rab GTPases-dependent endocytic pathways regulate neuronal migration and maturation through N-cadherin trafficking. Neuron. 67:588–602. 2010. View Article : Google Scholar : PubMed/NCBI

30 

Kessler D, Gruen GC, Heider D, Morgner J, Reis H, Schmid KW and Jendrossek V: The action of small GTPases Rab11 and Rab25 in vesicle trafficking during cell migration. Cell Physiol Biochem. 29:647–656. 2012. View Article : Google Scholar : PubMed/NCBI

31 

Liao X, Du Y, Morse HC III, Jenkins NA and Copeland NG: Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins. Oncogene. 14:1023–1029. 1997. View Article : Google Scholar : PubMed/NCBI

32 

Laflamme C, Assaker G, Ramel D, Dorn JF, She D, Maddox PS and Emery G: Evi5 promotes collective cell migration through its Rab-GAP activity. J Cell Biol. 198:57–67. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Hu L, Wen JM, Sham JS, Wang W, Xie D, Tjia WM, Huang JF, Zhang M, Zeng WF and Guan XY: Establishment of cell lines from a primary hepatocellular carcinoma and its metastatis. Cancer Genet Cytogenet. 148:80–84. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tang J, Ou J, Xu C, Yi C, Xue F, Xu L, Lai F, Tang J, Li S, Kang T, Kang T, et al: EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Oncol Rep 38: 2251-2258, 2017.
APA
Tang, J., Ou, J., Xu, C., Yi, C., Xue, F., Xu, L. ... Wang, B. (2017). EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Oncology Reports, 38, 2251-2258. https://doi.org/10.3892/or.2017.5862
MLA
Tang, J., Ou, J., Xu, C., Yi, C., Xue, F., Xu, L., Lai, F., Tang, J., Li, S., Kang, T., Ding, W., Wang, B."EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy". Oncology Reports 38.4 (2017): 2251-2258.
Chicago
Tang, J., Ou, J., Xu, C., Yi, C., Xue, F., Xu, L., Lai, F., Tang, J., Li, S., Kang, T., Ding, W., Wang, B."EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy". Oncology Reports 38, no. 4 (2017): 2251-2258. https://doi.org/10.3892/or.2017.5862
Copy and paste a formatted citation
x
Spandidos Publications style
Tang J, Ou J, Xu C, Yi C, Xue F, Xu L, Lai F, Tang J, Li S, Kang T, Kang T, et al: EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Oncol Rep 38: 2251-2258, 2017.
APA
Tang, J., Ou, J., Xu, C., Yi, C., Xue, F., Xu, L. ... Wang, B. (2017). EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy. Oncology Reports, 38, 2251-2258. https://doi.org/10.3892/or.2017.5862
MLA
Tang, J., Ou, J., Xu, C., Yi, C., Xue, F., Xu, L., Lai, F., Tang, J., Li, S., Kang, T., Ding, W., Wang, B."EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy". Oncology Reports 38.4 (2017): 2251-2258.
Chicago
Tang, J., Ou, J., Xu, C., Yi, C., Xue, F., Xu, L., Lai, F., Tang, J., Li, S., Kang, T., Ding, W., Wang, B."EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy". Oncology Reports 38, no. 4 (2017): 2251-2258. https://doi.org/10.3892/or.2017.5862
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team